Lepercq De Neuflize Asset Management’s LAVA Therapeutics LVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$40.9K	Buy	31,000 +8,000	+35%	+$10.6K	0.03%	9
2025 Q1	$29.2K	Buy	+23,000	New	+$29.2K	0.03%	11